Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01349660 |
| Title | Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | SCRI Development Innovations, LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Yale School of Medicine | New Haven | Connecticut | 06520 | United States | Details | |
| Florida Cancer Specialists | Fort Myers | Florida | 33916 | United States | Details | |
| Florida Hospital Cancer Institute | Orlando | Florida | 32804 | United States | Details | |
| Florida Cancer Specialists | Saint Petersburg | Florida | 33705 | United States | Details | |
| Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | United States | Details | |
| Grand Rapids Oncology Program | Grand Rapids | Michigan | 49503 | United States | Details | |
| Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | United States | Details | |
| Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details |